COMMUNIQUÉS West-GlobeNewswire

Go North Hemp Forecasts 100% Year-Over-Year Revenue Growth in 2025, Strengthening Market Leadership in Next-Gen Hemp Ingredients
08/09/2025
TIGARD, Ore., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Go North Hemp, a U.S. wholesale supplier of hemp-derived ingredients, today announced it is on track to double annual revenue in 2025 versus 2024, supported by expanding [...]
Shiny Smile Veneers Surpasses 100,000 Smiles Transformed in 2025 as Demand for Lifestyle Dental Health Solutions Grows
08/09/2025
Shiny Smile Veneers, founded by practicing dentist Dr. Dean, has officially surpassed 100,000 customers in 2025. The milestone highlights the rising demand for affordable, custom-made removable veneers that combine [...]
Most Popular Legal Steroids for Muscle Building from CrazyBulk: Best Selling Steroid Alternatives for Muscle Growth and Cutting in 2025
08/09/2025
New York City, NY, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Introduction: What are the best legal steroid alternatives for muscle growth and fat loss from Crazybulk’s supplement range. In 2025, demand for legal steroid [...]
Persephone Biosciences Hits 10,000 Families on Waitlist for First-of-Its-Kind Infant Synbiotic
08/09/2025
In just over a month, 10,000 parents and caregivers joined the waitlist for Persephone’s science-driven synbiotic designed to restore critical gut microbes in babies. The milestone underscores the urgent demand for [...]
Tren Cycle for Bodybuilding: CrazyBulk Introduce Test and Tren Stack for Muscle Growth, Dosage, Benefits & Results
08/09/2025
New York City, NY, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Introduction: The Ultimate Tren Cycle and Why the Tren and Test Conversation Dominates Modern Bodybuilding Tren and Test dominate the narrative of contemporary [...]
Beyond Air Announces Exercise of Warrants for $3.25 Million of Gross Proceeds
08/09/2025
GARDEN CITY, N.Y., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of [...]
Claisen Launches Direct-to-Consumer Personalized Kits for Gastrointestinal Diseases (Heartburn, Bloating, and Gas)
08/09/2025
BOSTON, MA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Claisen Inc. , a telemedicine and digital gastrointestinal health company, today announced the launch of personalised, direct-to-consumer gut health kits that help patients [...]
Nora Mental Health Opens New Location in Dallas, TX, Bringing Compassionate, Accessible Mental Health Care to the Community
08/09/2025
Dallas, TX , Sept. 08, 2025 (GLOBE NEWSWIRE) -- Nora Mental Health is excited to announce the grand opening of its newest clinic in Dallas, Texas, located at 8140 Walnut Hill Ln, Suite 835. The new location reflects the [...]
Abivax Presents First Half 2025 Financial Results
08/09/2025
Abivax Presents First Half 2025 Financial Results PARIS, France, September 8, 2025, 10:00 p.m. CEST – Abivax SA (Euronext Paris: FR0012333284 – ABVX / Nasdaq – ABVX) (“Abivax” or the “Company”), a clinical-stage [...]
Dianthus Therapeutics, Inc. Announces Proposed $150 Million Underwritten Public Offering
08/09/2025
NEW YORK and WALTHAM, Mass., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement [...]
Rapport Announces Proposed Public Offering of Common Stock
08/09/2025
BOSTON and SAN DIEGO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small [...]
NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025
08/09/2025
EDEN PRAIRIE, Minn., Sept. 08, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and [...]
Ultragenyx Announces Positive Longer-term Data from Phase 3 Study of DTX401 AAV Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia (GSDIa)
08/09/2025
At Week 96 participants experienced even greater reductions in daily cornstarch intake while maintaining low levels of hypoglycemia, improved levels of euglycemia and improved fasting tolerance Phase 3 results are [...]
Enovis Corporation Announces Time Change for Presentation at Baird 2025 Global Healthcare Conference
08/09/2025
Wilmington, DE, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will now present at the Baird 2025 Global Healthcare [...]
Immix Biopharma Announces Strategic Investment by Houston based Goose Capital, led by founding member Dr. Nancy T. Chang
08/09/2025
LOS ANGELES, CA, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“Immix”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other [...]
PharmAla Completes Import of LaNeo MDMA for US Distribution
08/09/2025
TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]
Sienna Senior Living Announces the Opening of Its Long-Term Care Community in North Bay and Retirement Community in Brantford, Ontario
08/09/2025
MARKHAM, Ontario, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (" Sienna " or the " Company ") (TSX: SIA) announced today that it has officially opened its Northern Heights Community, the Company’s first [...]
Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Wayrilz™ (rilzabrutinib)
08/09/2025
LOUISVILLE, Ky., Sept. 08, 2025 (GLOBE NEWSWIRE) -- Onco360 ® , the nation’s leading independent specialty pharmacy, has been selected as a pharmacy partner by Sanofi for Wayrilz (rilzabrutinib), which has been approved [...]
NurExone Receives U.S. Patent Allowance for Exosome Manufacturing, Strengthening Supply Chain Readiness
08/09/2025
TORONTO and HAIFA, Israel, Sept. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a pioneering biopharmaceutical company developing exosome-based [...]

Pages